Clinical Trial Update: Relapse Prevention in First Episode Schizophrenia: a 5 Year Trial [NA]

View source ↗

Summary

A clinical trial update describing a five-year study on relapse prevention in individuals with first-episode schizophrenia. Sponsor: Academisch Medisch Centrum …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Schizophrenia | NA | Status: UNKNOWN